Ado-trastuzumab emtansine Intravenous and Chromium picolinate
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Chromium picolinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: chromium picolinate
Brand name: Cr-GTF, CRM, Chromium GTF
Synonyms: Chromium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Chromium supplement Oral, Parenteral
- Ado-trastuzumab emtansine Intravenous-Cialis
- Ado-trastuzumab emtansine Intravenous-Ciclesonide (Oral Inhalation)
- Ado-trastuzumab emtansine Intravenous-Ciclesonide (Systemic, Oral Inhalation)
- Ado-trastuzumab emtansine Intravenous-Ciclesonide eent
- Ado-trastuzumab emtansine Intravenous-Ciclesonide inhalation
- Chromium picolinate-Adox Pak 2/100
- Chromium picolinate-Adoxa
- Chromium picolinate-Adoxa CK
- Chromium picolinate-Adoxa Pak
- Chromium picolinate-Adoxa Pak 1/100
- Chromium picolinate-Adoxa Pak 1/150